ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag public outreach immunology neuroscience

A silver tree showing roots and branches in a circle on a blue background.
Onward and Upward!
Kristie Nybo, PhD | Sep 8, 2023 | 9 min read
At The Scientist, we are strengthening our roots while reaching for the sky.
Cancer cell
Interrogating the Complexities of the Tumor Microenvironment
Alison Halliday, PhD, Technology Networks | May 19, 2023 | 5 min read
Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
Citation Analysis Identifies 1994's Most-Cited Authors, Hottest Topics
The Scientist Staff | May 28, 1995 | 8 min read
Editor's Note: Since 1993, the newsletter Science Watch has ranked the year's most cited scientists and research papers. Based on records compiled by the Philadelphia-based Institute for Scientific Information (ISI), analysts prepared such rosters for 1994. Researchers are ranked by their number of "hot papers." An article is considered "hot" if it has garnered a substantially greater number of citations, within a two-year period, than other papers in similar disciplines. For instance, the 199
How Well Do Mice Model Humans?
Ricki Lewis | Oct 25, 1998 | 8 min read
STRIKING RESEMBLANCE: James Croom, who studies Down syndrome mice at North Carolina State University, says the animals are providing valuable information useful to humans. When a page-one article in the May 3, 1998, Sunday New York Times portrayed angiogenesis inhibitors that fight cancer in mice as being possible just around the corner for humans, criticism for raising false hopes erupted. Merely 10 weeks later, however, when researchers from the University of Hawaii reported cloning the fi
Trading Pipette for Pen, Assay for Essay
Douglas Steinberg | May 23, 1999 | 8 min read
In 1993, Jamie Zhang was in a career funk not uncommon among biologists with Ph.D.s. Three years out of graduate school, she was in her second postdoctoral job, studying the molecular biology of cancer at Rutgers University. But she wasn't satisfied in the lab--and hadn't been for a long time. "Everybody's unhappy as a graduate student," she observes. "Then in my first postdoc, I just felt like I was spinning my wheels." She blamed the feeling on her doubts about her project and on the differen
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,
Turmoil Besets Wistar In Wake Of Koprowski's Ouster
Jean Wallace | Mar 1, 1992 | 10+ min read
The Wistar Institute in Philadelphia marks its 100th anniversary this year, but the mood at the nation's oldest independent biomedical research facility is hardly jubilant. The institute has been in turmoil for the last year, after the abrupt ouster of longtime director Hilary Koprowski, the famed virologist and immunologist who transformed Wistar from a dilapidated museum into a world-renowned research center. The commotion recently was stirred up further, when the 75-year-old Koprowski file

Run a Search

ADVERTISEMENT